Monitoring salivary melatonin concentrations in children with sleep disorders using liquid chromatography-tandem mass spectrometry

Therapeutic Drug Monitoring

Volumn 35, Issue 3, 2013, Pages 388-395

  Khan, Sohil A ^a,b   George, Rani ^a   Charles, Bruce G ^a   Taylor, Paul J ^c   Heussler, Helen S ^d   Cooper, David M ^d   McGuire, Treasure M ^d,e   Pache, David ^d   Norris, Ross L G ^a,b,d  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^e BOND UNIVERSITY   (Australia)

Author keywords

Circadian; LC MS MS; Melatonin; Monitoring; Sleep disorders

Indexed keywords

ACETONITRILE; FORMIC ACID; GLASS; MELATONIN; METHANOL; WATER;

ACCURACY; ADOLESCENT; ARTICLE; ATMOSPHERIC PRESSURE; CALIBRATION; CHILD; CONTROLLED STUDY; ELUTION; FEMALE; FLOW RATE; HUMAN; IONIZATION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MONITORING; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; SALIVA; SCHOOL CHILD; SLEEP DISORDER; TANDEM MASS SPECTROMETRY;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, LIQUID; CHROMATOGRAPHY, REVERSE-PHASE; FEMALE; HUMANS; MALE; MELATONIN; SALIVA; SLEEP DISORDERS, CIRCADIAN RHYTHM; TANDEM MASS SPECTROMETRY;

EID: 84880056279     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3182885cb2     Document Type: Article

References (33)

1. Lerner A, Case J, Takahashi Y, et al. Isolation of melatonin, a pineal factor that lightens melanocytes. J Am Chem Soc. 1958;80:2587.
2. Benloucif S, Burgess HJ, Klerman MD, et al. Measuring melatonin in humans. J Clin Sleep Med. 2008;4:66-69. (Pubitemid 352038675)
3. Vakkuri O. Diurnal rhythm of melatonin in human saliva. Acta Physiol Scand. 1985;124:409-412. (Pubitemid 15028832)
4. Quine L. Sleep problems in children with mental handicap. J Ment Defic Res. 1991;35:269-290.
5. Sack RL, Lewy AJ, Blood ML, et al. Melatonin administration to blind people: phase advances and entrainment. J Biol Rhythms. 1991;6:249-261.
6. Giannotti F, Cortesi F, Cerquiglini A. An open labelled study of controlled release melatonin in treatment of sleep disorders in children with Autism. J Autism Dev Disord. 2006;36:741-752. (Pubitemid 44284978)
7. Bendz LM, Scates AC. Melatonin treatment for insomnia in pediatric patients with attention-deficit/hyperactivity disorder. Ann Pharmacother. 2010;44:185-191.
8. Vitale AA, Ferrari CC, Aldana H, et al. Highly sensitive method for the determination of melatonin by normal-phase high-performance liquid chromatography with flurometric detection. J Chromatogr B. 1996: 681;381-384. (Pubitemid 26191833)
9. Hamase K, Hirano J, Kosai Y, et al. A sensitive internal standard method for the determination of melatonin in mammals using precolumn oxidation reversed-phase high performance liquid chromatography. J Chromatogr B. 2004;811:237-241. (Pubitemid 39446771)
10. Romsing S, Ulfberg Y, Bergzvist Y. Determination of melatonin in human plasma with solid-phase extraction, high-performance liquid chromatography and fluorescence detection. Scand J Clin Lab Invest. 2003; 63:81-88. (Pubitemid 36461153)
11. Arendt J, Bojkowski C, Franey C, et al. Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol. J Clin Endocrinol Metab. 1985;60:1166-1173. (Pubitemid 15064777)
12. Peniston-Bird JF, Di WL, Street CA, et al. An enzyme immunoassay for 6-sulphatoxymelatonin in human urine. J Pineal Res. 1996;20:51-56. (Pubitemid 126733174)
13. Di WL, Kadva A, Djahanbakhch, et al. Radioimmunoassay of bound and free melatonin in plasma. Clin Chem. 1998;44:304-310. (Pubitemid 28087729)
14. Voultsios A, Kennaway D, Dawson D. Salivary melatonin as a circadian phase marker: validation and comparison to plasma melatonin. J Biol Rhythms. 1997;12:457-466. (Pubitemid 127478560)
15. Gröschl M. Current status of salivary hormone analysis. Clin Chem. 2008;54:1759-1769.
16. Simonin G, Bru L, Lelievre E, et al. Determination of melatonin in biological fluids in the presence of the melatonin agonist S 20098: comparison of immunological techniques and GC-MS methods. J Pharm Biomed Anal. 1999;21:591-601. (Pubitemid 29512225)
17. Motoyama A, Kanda T, Namba R. Direct determination of endogenous melatonin in human saliva by column-switching semi-microcolumn liquid chromatography/mass spectrometry with on-line analyte enrichment. Rapid Commun Mass Spectrom. 2004;18:1250-1258. (Pubitemid 38843146)
18. Eriksson K, Ostin A, Levin JO. Quantification of melatonin in human saliva by liquid chromatography-tandem mass spectrometry using stable isotope dilution. J Chromatogr B. 2003;794:115-123. (Pubitemid 36897632)
19. de Almeida EA, Klitzke CF, Martinez GR, et al. Synthesis of internal labeled standards of melatonin and its metabolite N1-Acetyl-N2-formyl-5-methoxy kynuramine for their quantification using an on-line liquid chromatography- electrospray tandem mass spectrometry system. J Pineal Res. 2004;36:64-71. (Pubitemid 38130291)
20. Jensen MA, Hansen AM, Abrahamsson P, et al. Development and evaluation of a liquid chromatography tandem mass spectrometry method for simultaneous determination of salivary melatonin, cortisol and testosterone. J Chromatogr B. 2011;879:2527-2532.
21. Sieghart W, Ronca E, Drexler G, et al. Improved radioimmunoassay of melatonin in serum. Clin Chem. 1987;33:604-605. (Pubitemid 17157890)
22. Chegini S, Ehrhart-Hofmann B, Kaider A, et al. Direct enzyme-linked immunosorbent assay and a radioimmunoassay for melatonin compared. Clin Chem. 1995;41:381-386.
23. Krouwer JS. Observations on within-run and day-to-day precision. Clin Chem. 1981;27:202.
24. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem. 2003;75:3019-3030. (Pubitemid 36830428)
25. de Almeida EA, Mascio P, Harumi T, et al. Measurement of melatonin in body fluids: standards, protocols and procedures. Childs Nerv Syst. 2011; 27:879-891.
26. Taylor PJ. Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clin Biochem. 2005;38:328-334. (Pubitemid 40342863)
27. Annesley T. Ion suppression in mass spectrometry. Clin Chem. 2003;49: 1041-1044. (Pubitemid 36751088)
28. Morelius E, Nelson N, Theodorsson E. Saliva collection using cotton buds with wooden sticks: a note of caution. Scand J Clin Lab Invest. 2006;66:15-18. (Pubitemid 43220756)
29. Charles B, Touitou Y, Selmaoui B. A population pharmacokinetic turnover and surge-function model for describing melatonin biological rhythm in healthy male subjects. J Pharm Sci. 2008;98: 782-790.
30. Leston J, Mottolese C, Champier J, et al. Contribution of the daily melatonin profile to diagnosis of tumours of the pineal region. J Neurooncol. 2009;93:387-394.
31. Miles A, Philbrick DR, Grey JE. Salivary melatonin estimation in assessment of pineal-gland function. Clin Chem. 1989;35:514-515.
32. Mallo C, Zaidan R, Galy G, et al. Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection. Eur J Clin Pharmacol. 1990;38:297-301. (Pubitemid 20137485)
33. Duffull S, Waterhouse T, Eccleston J. Some considerations on the design of population pharmacokinetic studies. J Pharmacokinet Pharmacodyn. 2005;32:441-457. (Pubitemid 41738435)